Medical Affairs > Medical Science Liaison

Medical Science Liaison Research



Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups 
Biopharmaceutical and medical device companies find it increasingly challenging to deliver exceptional services to a diverse set of customers that may include regional Thought Leaders, important Clinical Investigators, local Opinion Leaders, Payer and Government Thought Leaders, and various internal stakeholders... (ID PSM-279)
Companies Profiled: Advanced Biohealing, Allergan, Amylin, AstraZeneca, more ...
Price: $6800.00   Free Excerpt Available


Best Practices in Globalizing MSL & Field-Based Medical Specialist Programs 
Biopharmaceutical organizations are increasingly adopting global MSL & Field-Based Medical Specialist (FBMS) programs to achieve corporate goals within regional markets... (ID POP-263)
Companies Profiled: Abbvie, Medivation, Alkermes, Santen, more ...
Price: $6200.00   Free Excerpt Available


Benchmarking the Roles and Responsibilities for U.S.-Based Field Medical Team Interactions with Managed Care Customers 
Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Companies Profiled: Abbvie, Bayer, Biogen, Boehringer Ingelheim, more ...
Price: $6000.00   Free Excerpt Available


Roles, Resourcing and Management of Medical Science Liaisons 
As the medical science liaison (MSL) function continues to gain importance in building and strengthening KOL relationships, medical affairs leaders are continually re-assessing their MSL management practices to be successful in the competitive environment... (ID PSM-234)
Companies Profiled: Abbott Labs, Jazz Pharmaceuticals, Kadmon Pharmaceuticals, Covidien, more ...
Price: $5675.00   Free Excerpt Available


Investigator Initiated Trials Management 
As pharmaceutical and medical device companies improve their investigator-initiated trial (IIT) programs, it is critical to properly vet each proposal and approve the ones that demonstrate scientific merit and align with corporate objectives... (ID POP-282)
Companies Profiled: Abbvie, Allergan, Alnylam Pharmaceuticals, Bayer, more ...
Price: $5500.00   Free Excerpt Available


Strategies for Developing Strong Field-Based Medical Teams 
As companies bring diverse sets of field-based medical liaisons into the field to work with physicians, payers and patients, it becomes imperative to clarify what roles each type of liaison might serve... (ID POP-278)
Companies Profiled: AbbVie, AstraZeneca, Bayer, EMD Serono, more ...
Price: $5500.00   Free Excerpt Available


Medical Affairs Strategies to Deliver Value to Payer Groups 
In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284)
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, more ...
Price: $5000.00   Free Excerpt Available


Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups Within the Medical Device Industry 
Medical device companies find it increasingly challenging to deliver exceptional services to a diverse set of customers that may include regional Thought Leaders, important Clinical Investigators, local Opinion Leaders, Payer and Government Thought Leaders, and various internal stakeholders... (ID PSM-281)
Companies Profiled: Advanced Biohealing, Boston Scientific, Gambro, G.E. Healthcare, more ...
Price: $4000.00   Free Excerpt Available


Deploying the iPad or Android-Based Tablet to Medical Science Liaison Teams: Benchmarking Training and Effectiveness 
As Medical Science Liaisons (MSLs) increasingly face restricted access to physicians and KOLs, it is important for biopharmaceutical and medical device companies to empower MSLs with new processes and tools that facilitate rapid and effective customer engagement... (ID POP-286)
Companies Profiled: Abbott, Abbvie, Baxter, Boehringer Ingelheim, more ...
Price: $4000.00   Free Excerpt Available


The iPad: How MSLs Use It to Deliver Science and Data to HCPs 
As pharma companies find it more difficult to connect with physicians and KOLs, advances and access to technology have opened doors for bio-pharmaceutical companies to adapt and enhance new processes and tools for superior performance and gain competitive edge in the market... (ID POP-252)
Companies Profiled: Abbott Animal Health, Abbvie, Acorda Therapeutics, Amgen, more ...
Price: $2500.00   Free Excerpt Available


Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies 
The growing demand for scientific and medical data in the biopharmaceutical industry has pushed organizations to develop effective KOL engagement strategies for their field-based medical and field-based outcomes and pricing group... (ID POP-288)
Companies Profiled: Avanir, Boehringer Ingelheim, Galderma, GlaxoSmithKline , more ...
Price: $2200.00   Free Excerpt Available


 

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information